ABSTRACT
Myoepithelial carcinoma is a malignant tumor that can differentiate towards myoepithelial cells and commonly occur in the salivary glands. There have been only a few reports of primary cutaneous myoepithelial carcinoma; however, most cases showed subcutaneous involvement and could also be diagnosed as soft tissue myoepithelial carcinoma arising from the subcutis with dermal involvement. It may thus be impossible to distinguish a primary cutaneous from a soft tissue myoepithelial carcinoma. Herein, we describe a case of myoepithelial carcinoma on the shoulder in an 85-year-old Japanese woman. The tumor was located in the whole dermis and subcutis; therefore, it could be diagnosed as either a cutaneous or soft tissue myoepithelial carcinoma. We reviewed previous cases of primary cutaneous and soft tissue myoepithelial carcinomas and compared their clinical and immunohistological features. We found no obvious differences in anatomical distribution or immunohistochemical findings. However, the recurrence rate of cutaneous myoepithelial carcinomas seems to be lower than that of soft tissue carcinomas. Such a difference may be attributable to the adequate surgical margin in cutaneous carcinomas compared with the deep-seated soft tissue carcinomas. The metastatic frequency did not significantly differ between the two types. Although we could summarize from only a small number of cases, these results indicate the difficulty in distinguishing between cutaneous and soft tissue myoepithelial carcinomas; furthermore, it may not be suitable to distinguish them on the basis of aggressive behavior.
Subject(s)
Carcinoma/diagnosis , Lung Neoplasms/secondary , Myoepithelioma/diagnosis , Pleural Neoplasms/secondary , Skin Neoplasms/diagnosis , Aged, 80 and over , Axilla , Biomarkers/metabolism , Carcinoma/metabolism , Carcinoma/pathology , Dermis/pathology , Fatal Outcome , Female , Humans , Immunohistochemistry , Lymph Node Excision , Lymph Nodes/pathology , Lymphatic Metastasis , Myoepithelioma/metabolism , Myoepithelioma/pathology , Shoulder , Skin Neoplasms/metabolism , Skin Neoplasms/pathology , Subcutaneous Tissue/pathology , Tomography, X-Ray ComputedSubject(s)
Acetaminophen/adverse effects , Antitussive Agents/adverse effects , Bromisovalum/adverse effects , Codeine/analogs & derivatives , Diphenhydramine/adverse effects , Drug Eruptions/diagnosis , Drug Eruptions/etiology , Dyphylline/adverse effects , Ephedrine/analogs & derivatives , Acetaminophen/administration & dosage , Administration, Oral , Adolescent , Antitussive Agents/administration & dosage , Bromisovalum/administration & dosage , Codeine/administration & dosage , Codeine/adverse effects , Diphenhydramine/administration & dosage , Drug Combinations , Dyphylline/administration & dosage , Eosinophils/immunology , Ephedrine/administration & dosage , Ephedrine/adverse effects , Female , Humans , Immunization , Skin Tests , TabletsABSTRACT
Pulmonary tumor thrombotic microangiopathy is an unusual malignancy-related respiratory complication characterized by multiple microthrombi and intimal myofibroblast proliferation. Its clinical manifestation is subacute respiratory failure with pulmonary hypertension. Herein is reported a case of pulmonary tumor thrombotic microangiopathy associated with gastric signet ring cell carcinoma. A 51-year-old woman with gastric cancer died of subacute respiratory failure. Autopsy showed gastric signet ring cell carcinoma with diffuse metastasis of pulmonary lymphatics and pleurae; every organ examined lacked a space-occupying tumor mass. Histologically, proliferated intimal myofibroblasts obliterated most of the pulmonary vascular lumen, and a few stenosed vascular lumina contained cancer cells. In addition, pulmonary vasculature associated with intimal proliferation contained microthrombi. Most cancer cells in the stomach and pulmonary lymphatics were typical signet ring cells, whereas those in vascular lesions were cells of poorly differentiated adenocarcinoma without mucous production. Consistent with a previous report, the latter expressed vascular endothelial growth factor (VEGF) and tissue factor (TF). The proliferated intimal myofibroblasts also expressed type 2A serotonin receptor (5-HT(2A)). These findings suggest that local expression of VEGF, TF, and 5-HT(2A) may be linked to the pathogenesis of this unusual pulmonary complication.
